Theriva Biologics, Inc 10-K for FY2025
Theriva Biologics, Inc. (TOVX)
10-K
2026-03-12
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
Theriva Biologics, Inc filed this 10-K on March 12, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $23.74M
- compared with a net loss of $25.65M a year earlier
- Diluted EPS
- -$2.08
- compared with -$19.03 a year earlier